SBI Securities’s Faeth Therapeutics FTH Stock Holding History

SBI Securities’s Portfolio FTH Stock Details FTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$100	Hold	4	–	–	﹤0.01%	3512
2026 Q1	$126	Hold	4	–	–	﹤0.01%	3357
2025 Q4	$43	Sell	4 -145	-97%	-$1.4K	﹤0.01%	3607
2025 Q3	$1.41K	Hold	149	–	–	﹤0.01%	2558
2025 Q2	$1.28K	Buy	149 +144	+2,880%	+$1.03K	﹤0.01%	2569
2025 Q1	$36	Buy	5 +1	+25%	+$10	﹤0.01%	3734
2024 Q4	$35	Buy	+4	New	+$40	﹤0.01%	3712

Other funds holding FTH

RIS

Richmond Investment Services Mequon, Wisconsin $316M AUM 30.61% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PWA

Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return

SBI Securities's FTH Position: Q2 2026 in Review

SBI Securities held its Faeth Therapeutics (FTH) position steady in Q2 2026 at 4 shares worth $100. The position accounts for ﹤0.01% of the portfolio, ranked #3512.

SBI Securities first reported a position in FTH in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.41K in Q3 2025. 4 funds tracked by Wall St. Rank hold FTH as of Q2 2026.

SBI Securities held 4 shares of Faeth Therapeutics worth $100 as of Q2 2026.
SBI Securities left its Faeth Therapeutics share count unchanged in Q2 2026.
Faeth Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3512 holding.
SBI Securities first reported a position in Faeth Therapeutics in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Faeth Therapeutics position peaked at $1.41K in Q3 2025.
4 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.